kartellrechtler.de › English

Healthcare, Pharmaceuticals and Medical Technology

· Editorial team: lawyers of horak. Rechtsanwälte

Deutsch · English · Français · Español

In the healthcare market, patent protection, regulation and competition law meet. The European Commission pursues pay-for-delay agreements, excessive prices and abusive strategies against generics; the Bundeskartellamt reviews hospital mergers and purchasing power.

Typical issues

  • Settlements in patent disputes between originator and generic manufacturers
  • Pricing by sole suppliers, including for older medicines
  • Distribution via wholesalers and pharmacies, parallel trade
  • Hospital mergers and cooperation between hospitals
  • Hospital purchasing groups, tenders by health insurance funds
  • Medical technology: spare parts, maintenance, tying of devices and consumables

Special features

In 2024 the Commission fined a pharmaceutical manufacturer for misusing the patent system and disparaging a competing product. Competition law applies to statutory health insurance funds only to a limited extent; it applies fully to service providers.

Practical examples

Practical example 1: Settlement in a patent dispute

An originator and a generic manufacturer want to settle a patent dispute.

We structured the settlement so that no value transfer for a delayed market entry was agreed and documented the agreement.

Practical example 2: Merger of two hospitals

Two hospitals in neighbouring districts want to merge.

We submitted patient flow analyses and presented the arguments on healthcare provision; clearance was granted in phase 1.

Practical example 3: Maintenance of large equipment

A manufacturer of imaging equipment only releases service codes to its own technicians.

For an independent service company, we obtained access to codes and spare parts on fair terms.

Practical example 4: Price increase by a sole supplier

A hospital group considers a sharp price increase for a niche medicine abusive.

We substantiated a complaint to the Commission with cost and price comparisons.

Frequently asked questions

What are pay-for-delay agreements?

Settlements of patent disputes in which the originator transfers value to the generic manufacturer in return for later market entry. The Commission and the Court of Justice regularly treat them as restrictions by object.

Are hospital mergers subject to merger control?

Yes, if the turnover thresholds are met. The Bundeskartellamt examines in particular whether patients in a region still have alternatives.

Does competition law apply to health insurance funds?

Only to a limited extent, insofar as statutory health insurance funds fulfil their statutory mandate. It applies fully to pharmaceutical companies, medical device manufacturers, hospitals and pharmacies.

More industries

Discuss your matter

Describe your matter to us by e-mail or telephone, in English, French, Spanish or German. We usually respond within one working day with an initial assessment. The initial assessment is free of charge and non-binding. In the event of an ongoing dawn raid, please call us directly: 0511 35 73 56-0.

The information on this website is for general information only and does not constitute legal advice in an individual case. The case examples have been anonymised and simplified.

Legal notice · Privacy · Terms of engagement (German)